Study evaluates the brain-penetrant PI3K/mTOR inhibitor in treatment-resistant epilepsy associated with focal cortical ...
Viva-Thera combines atomic-resolution structural research with XtalPi’s AI and automation platform to pursue HIV prevention, ...
Expansion Opportunity Beyond Dercum's Disease—Study findings support the potential development of CBL-514 for Lipedema, a ...
Mayo Clinic Laboratories and Pathology Asia Holdings (PAH) have announced a strategic investment and collaboration aimed at ...
GenScript Biotech subsidiary targets commercial-scale sugar reduction with 100-tonne annual capacity for Mellia® Brazzein, ...
Exclusive agreement adds BoomRay’s preclinical RLT programme to Novartis’ oncology pipeline, with potential milestone ...
Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, announced ...
ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of ...
Antibody expression: Tsingke works with multiple antibody formats, including scFv, VHH, Fab, and full-length IgG. Its high-throughput workflow can process up to 1,500 candidates per day, with ...
European Commission authorisation marks the first global regulatory approval for obicetrapib, offering new oral, non-statin ...
Figure 1. The 2026 approvals timeline: one dot per new active substance, by month and authority. Solid dots are ...
Accro Bioscience Inc. (Accro Bio), a clinical-stage biotechnology company pioneering the development of novel therapeutics ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results